Thursday, May 16, 2024
5/16/2024
Abstract: Type 2 diabetes is a metabolic disorder that causes hyperglycemia in patients. Loss of functional beta-cell mass is a hallmark of progression from insulin resistance to overt diabetes. New evidence indicated altered identity of ß-cells due to beta-cell dedifferentiation is believed to be a new mechanism of ß-cell loss in diabetes. However, the mechanism of ß-cell dedifferentiation remains to be investigated. microRNAs (miRNAs) are small non-coding RNAs that regulate ß- cell function and survival by inhibiting specific target gene expression. We discovered that miR- 483 is highly expressed in ß-cells, but much less in a-cells. Mice with ß-cell specific deletion of miR-483 exhibited diet-induced hyperglycemia and reduced glucose tolerance without changing in ß-cell mass. RNA-seq analysis revealed that miR-483 inactivation resulted in a marked increase in oxidative stress markers including gamma-glutamyltransferase (Ggt1), suggesting that miR- 483 deficiency activates oxidation stress, which causes mitochondrial dysfunction and simultaneously triggers an adaptive antioxidant stress response. Notably, miR-483 deletion increases expression of a ß-cell disallowed gene Aldh1a3, pointing to a direction linking dysregulation of microRNAs with ß-cell dedifferentiation. The objective of this project is to identity new factors/pathways initiating beta-cell dedifferentiation. We hypothesize that miR-483 maintains ß-cell identity by preventing beta-cell dedifferentiation, and miR-483 inactivation induces alteration of antioxidant defense that in turn leads to mitochondrial dysfunction. We will test this hypothesis with the following Aims: Aim 1. Determine the ß-cell identity in miR-483 deficient mice after HFD feeding. Aim 2. Elucidate mechanism(s) by which miR-483 maintains ß- cell identity. Moreover, the therapeutic potential of miR-483 in preventing ß-cell dedifferentiation in human islets will be examined. The results obtained from this project will help understand the underlying mechanisms of ß-cell dedifferentiation and guide therapeutical treatments for diabetes. This project will also provide research opportunities for both undergraduate and graduate students.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
